Evidence map›Paper›PMID 30691044›Full record

ArticleInternational journal of molecular sciences2019

Association of the

Heidi Miedl, Jürgen Lebhard, Lisa Ehart, Martin Schreiber

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Comprehensive Meta-Analysis on the Impact of theCurrent pharmaceutical design · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Associations ofJournal of clinical medicine · 2021
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Heidi MiedlDepartment of Obstetrics & Gynecology and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria. heidi.miedl@meduniwien.ac.at.
Jürgen Lebhard
Lisa Ehart
Martin Schreiber
Comprehensive Cancer Center Vienna · AT

Funding

Oesterreichische Nationalbank 12994
6 · The paper itself

Abstract

SNP309T>G (rs2279744) and SNP285G>C (rs117039649) in the

Indexed as

Polymorphism, Single NucleotideAgedAge of OnsetAustriaBreast NeoplasmsCase-Control StudiesDisease ProgressionFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansLinkage DisequilibriumMiddle AgedPrognosisPromoter Regions, GeneticMDM2 protein, humanProto-Oncogene Proteins c-mdm2TP53 protein, humanTumor Suppressor Protein p53age at onsetBreast cancerbreast cancer riskMDM2prognosisSNP285 (rs117039649)SNP309 (rs2279744)survivalTP53 mutation

Identifiers

PMID30691044
PMCPMC6387136
OpenAlexW2911904213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.